Investigation of thyroid, head, and neck cancers with PET

Hongming Zhuang; Rakesh Kumar; Susan Mandel; Abass Alavi

doi:10.1016/j.rcl.2004.07.006

Investigation of thyroid, head, and neck cancers with PET

Radiol Clin North Am. 2004 Nov;42(6):1101-11, viii. doi: 10.1016/j.rcl.2004.07.006.

Authors

Hongming Zhuang¹, Rakesh Kumar, Susan Mandel, Abass Alavi

Affiliation

¹ Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, 110 Donner Building, Philadelphia, PA 19104, USA.

PMID: 15488560
DOI: 10.1016/j.rcl.2004.07.006

Abstract

PET with [(18)F]-fluorodeoxyglucose (FDG) has been accepted as a useful imaging modality for the diagnosis of a variety of malignancies. This article discusses the use of FDG-PET in the management of patients with thyroid and head or neck cancers.

Publication types

Review

MeSH terms

Fluorodeoxyglucose F18
Head and Neck Neoplasms / diagnostic imaging*
Head and Neck Neoplasms / therapy
Humans
Neoplasm Recurrence, Local / diagnostic imaging
Neoplasm Staging
Positron-Emission Tomography*
Radiopharmaceuticals
Thyroid Neoplasms / diagnostic imaging*
Thyroid Neoplasms / therapy
Treatment Outcome

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18